Medigen focuses on the development of T Cell immunotherapies for solid tumors. They also focus on Vaccine safety and natural immunity.
Medigen Human Care
Category:
Venture
Main Business Area
T cell immunotherapies for solid tumors, vaccine safety and natural immunity
| Contact Details | 2022-Seoul Songpa-0349 [05835] 6, Jeongui-ro 7-gil, Songpa-gu, Tel. 02-555-9806E-mail. info@medizencare.com |
|---|
